跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROXI CONCENTRATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PROXI CONCENTRATE
Authorized
STANDARD
PROXI CONCENTRATE
ROCHESTER MIDLAND CORPORATION
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
53a8e51dfc2249f8
Company
ROCHESTER MIDLAND CORPORATION
Type
Standard
Approval Details
Approval Id
53a8e51dfc2249f8
Drug Approval Canada Name
PROXI CONCENTRATE
Product Name
PROXI CONCENTRATE
Status
Cancelled (Unreturned Annual)
Status Date
2024-01-08
Original Market Date
2016-02-05
Din
02443147
Drug Class
Disinfectant
Dosage Form
Liquid
Route Of Administration
Disinfectant (Hospital/HC Facilities) , Disinfectant (Food Premises) , Disinfectant (Institutional/Industrial)
Schedule
NON-PRESCRIPTION DRUGS
Ahfs
38:00.00
Atc Original
V07AV TECHNICAL DISINFECTANTS
Aig Number
0106899011
Company Name
ROCHESTER MIDLAND CORPORATION
Company Address
155 Paragon Drive Rochester New York United States 14624
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
53a8e51dfc2249f8
Type
Standard
Back to Health Canada Approvals